NVCT

• 2026-05-05 share offering or dilution eventrecentOpen filing ↗
  “…Public Entity There have been no material changes to the July 2022 Private Placement and the Securities Purchase Agreement, as…”
  +1 more passage from the same document

  • “…as previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC…”
• 2026-05-05 listing compliance noticerecentOpen filing ↗
  “…to restore our compliance with NASDAQ’s listing requirements, but we can provide no assurance that any such action taken by us…”
  +1 more passage from the same document

  • “…a delisting, we would likely take actions to restore our compliance with NASDAQ’s listing requirements, but we can provide no…”
• 2026-02-13 share offering or dilution eventrecentOpen filing ↗
  “…Amendment No. 1 to Sales Agreement (“Amendment No. 1”), dated February 13, 2026 (as amended, the “Sales Agreement”). The base…”
  +1 more passage from the same document

  • “…follows this explanatory note. The specific terms of any other securities to be offered pursuant to the base prospectus will…”
• 2026-02-13 capital return (buybacks/dividends)recentOpen filing ↗
  “…liability of its officers or directors to the company or its stockholders for monetary damages for a breach of fiduciary duty as…”
  +1 more passage from the same document

  • “…of the same series; · dates on which interest will accrue or the method for determining dates on which interest will accrue and…”
• 2026-02-11 share offering or dilution eventrecentOpen filing ↗
  “…referred to as the “Private Placement Warrants”. As of December 31, 2025, no additional placement warrants were exercised…”
  +1 more passage from the same document

  • “…placement agent warrants are exercisable. ​ b. At-the-Market Agreement On March 17, 2023, the Company filed a shelf registration…”
• 2026-02-11 listing compliance noticerecentOpen filing ↗
  “…to restore our compliance with NASDAQ’s listing requirements, but we can provide no assurance that any such action taken by us…”
  +1 more passage from the same document

  • “…a delisting, we would likely take actions to restore our compliance with NASDAQ’s listing requirements, but we can provide no…”
• 2026-02-11 Department of Justice inquiryrecentOpen filing ↗
  “…following product approval, where applicable, or commercialization are also subject to regulation by numerous regulatory authorities…”

Recorded SEC filings in plain language — not advice or a prediction.